Intraoperative neurophysiological monitoring

US Intraoperative Neuromonitoring Market Outlook 2020-2024, with Key Vendor Profiles

Retrieved on: 
Friday, March 20, 2020

DUBLIN, March 20, 2020 /PRNewswire/ -- The "Intraoperative Neuromonitoring Market in the US 2020-2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 20, 2020 /PRNewswire/ -- The "Intraoperative Neuromonitoring Market in the US 2020-2024" report has been added to ResearchAndMarkets.com's offering.
  • This report offers an up-to-date analysis regarding the current US market scenario, latest trends and drivers, and the overall market environment.
  • This study identifies rising adoption of remote IONM as the prime reason driving growth in the intraoperative neuromonitoring market in the US during the next few years.
  • A detailed analysis of around 25 vendors operating in the intraoperative neuromonitoring market in us 2020-2024, including some of the vendors such as Accurate Neuromonitoring LLC, Cadwell Industries Inc., Computational Diagnostics Inc., IntraNerve Neuroscience Holdings LC, Medtronic Plc, Natus Medical Inc., NeuroMonitoring Technologies Inc., Nihon Kohden Corp., NuVasive Inc. and SpecialtyCare Inc. .

The Intraoperative Neuromonitoring Market is expected to grow by USD 955.33 mn during 2020-2024, progressing at a CAGR of 10% during the forecast period

Retrieved on: 
Tuesday, March 17, 2020

Intraoperative Neuromonitoring Market In US 2020-2024 The analyst has been monitoring the intraoperative neuromonitoring market in us 2020-2024 and it is poised to grow by USD 955.33 mn during 2020-2024, progressing at a CAGR of 10% during the forecast period.

Key Points: 
  • Intraoperative Neuromonitoring Market In US 2020-2024 The analyst has been monitoring the intraoperative neuromonitoring market in us 2020-2024 and it is poised to grow by USD 955.33 mn during 2020-2024, progressing at a CAGR of 10% during the forecast period.
  • Our reports on intraoperative neuromonitoring market in us 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
  • The report offers an up-to-date analysis regarding the current us market scenario, latest trends and drivers, and the overall market environment.
  • In addition, rising adoption of remote ionm is anticipated to boost the growth of the intraoperative neuromonitoring market in us 2020-2024 as well.

Intraoperative Neuromonitoring Market in the US 2020-2024 | Evolving Opportunities with Accurate Neuromonitoring LLC and Cadwell Industries Inc. | Technavio

Retrieved on: 
Monday, March 16, 2020

In addition, the rising adoption of remote IONM is anticipated to boost the growth of the intraoperative neuromonitoring market in the US.

Key Points: 
  • In addition, the rising adoption of remote IONM is anticipated to boost the growth of the intraoperative neuromonitoring market in the US.
  • Major Five Intraoperative Neuromonitoring Companies in the US:
    Accurate Neuromonitoring LLC operates the business under the Services segment.
  • The company offers neuroscience services such as remote professional interpretation services, neurotelemetry/cEEG services, and intraoperative neuromonitoring services.
  • Intraoperative Neuromonitoring Market in US: Type Outlook (Revenue, USD Billion, 2020-2024)
    Intraoperative Neuromonitoring Market in US: Application Outlook (Revenue, USD Billion, 2020-2024)

Assure Holdings Continues Expansion in Texas with New Agreement in Greater Houston

Retrieved on: 
Tuesday, March 10, 2020

DENVER, March 10, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), has entered into an agreement with a surgeon group based in South Texas (the Agreement).

Key Points: 
  • DENVER, March 10, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), has entered into an agreement with a surgeon group based in South Texas (the Agreement).
  • Pursuant to the Agreement, Assure is providing IONM for one hospital serving residents in the Greater Houston area of Texas.
  • This agreement brings the total number of surgeons Assure is currently working with in Texas to 28 with more expected to be added to the platform soon.
  • We believe additional scale within Texas will benefit the Company as we negotiate in-network insurance agreements.

OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 6th Annual International Children’s Spine Symposium (ICSS)

Retrieved on: 
Monday, March 2, 2020

WARSAW, Ind., March 02, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (OrthoPediatrics) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it will attend the 6th Annual International Childrens Spine Symposium (ICSS), which will take place March 13-14, 2020 in Orlando, Florida.

Key Points: 
  • WARSAW, Ind., March 02, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (OrthoPediatrics) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it will attend the 6th Annual International Childrens Spine Symposium (ICSS), which will take place March 13-14, 2020 in Orlando, Florida.
  • The meeting offers a comprehensive program of lectures given an outstanding international faculty and cadaver labs centered on the cervical spine, lumbo-sacral junction, neuromonitoring, and various aspects of scoliosis.
  • Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics.
  • OrthoPediatrics currently markets 33 surgical systems that serve three of the largest categories within the pediatric orthopedic market.

Assure Holdings Continues Expansion into Central Michigan

Retrieved on: 
Thursday, February 20, 2020

DENVER, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), has entered into an agreement dated February 10, 2020, with a surgeon group based in Central Michigan (the Agreement).

Key Points: 
  • DENVER, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), has entered into an agreement dated February 10, 2020, with a surgeon group based in Central Michigan (the Agreement).
  • Pursuant to the Agreement, Assure is providing IONM for two medical facilities serving residents in Central Michigan and will be the preferred provider at one of those facilities.
  • We are pleased to expand our presence in Michigan and continue to see significant opportunities in the state, said John A. Farlinger, Assures executive chairman and CEO.
  • Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries.

Assure Holdings Completes Acquisition of Neuro-Pro Monitoring

Retrieved on: 
Tuesday, February 18, 2020

DENVER, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), is pleased to announce that it has completed (the Completed Agreement) the previously announced acquisition (the Acquisition) of all of the assets of Neuro-Pro Monitoring (Neuro-Pro), one of the largest IONM service providers in Texas.

Key Points: 
  • DENVER, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), is pleased to announce that it has completed (the Completed Agreement) the previously announced acquisition (the Acquisition) of all of the assets of Neuro-Pro Monitoring (Neuro-Pro), one of the largest IONM service providers in Texas.
  • From a financial perspective, commercial insurance payers are more profitable procedures to Assure than procedures covered for patients with government insurance.
  • John A. Farlinger, Assures executive chairman and CEO said, This acquisition is truly transformative for Assure.
  • Farlinger added, The final terms for this acquisition are highly favorable from a payment schedule and cost of capital perspective.

Assure Holdings Reaches Agreement with Clever Claims to acquire full ownership of Velocity Revenue Cycle, LLC

Retrieved on: 
Thursday, February 13, 2020

DENVER, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), has reached an agreement (the Agreement) with Clever Claims, LLC (Clever) to acquire Clevers 35% stake (the Clever Stake) in Velocity Revenue Cycle, LLC (Velocity), the joint venture billing and collection company.

Key Points: 
  • DENVER, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), has reached an agreement (the Agreement) with Clever Claims, LLC (Clever) to acquire Clevers 35% stake (the Clever Stake) in Velocity Revenue Cycle, LLC (Velocity), the joint venture billing and collection company.
  • Pursuant to the terms of the Agreement and effective on December 31, 2019, Clever assigned the Clever Stake, in exchange for nominal consideration, to Member Assure Billing, LLC, which is a subsidiary of the Company.
  • Over the past six months, we have overhauled our revenue cycle management system, resulting in a more timely and accurate filing of claims.
  • Under the terms of the agreement established in August 2019, Velocity served as Assures exclusive, in-house billing and collection vendor.

Assure Holdings Performs First Neuromonitoring Case in South Carolina

Retrieved on: 
Wednesday, January 29, 2020

DENVER, Colo., Jan. 29, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), is pleased to announce that it has performed its first neuromonitoring case in the state of South Carolina.

Key Points: 
  • DENVER, Colo., Jan. 29, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), is pleased to announce that it has performed its first neuromonitoring case in the state of South Carolina.
  • Over the past two years, Assure has extended its operations beyond its home state of Colorado and now provides IONM services in Texas, Louisiana, Utah, Pennsylvania, Michigan and South Carolina.
  • The Companys new Charleston, South Carolina area partner performed approximately 500 procedures in 2019.
  • Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries.

Assure Holdings Continues Expansion in Western Colorado

Retrieved on: 
Tuesday, January 28, 2020

DENVER, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), has entered into an agreement with a five-surgeon group based in Western Colorado (the Agreement).

Key Points: 
  • DENVER, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), has entered into an agreement with a five-surgeon group based in Western Colorado (the Agreement).
  • Pursuant to the Agreement, Assure is providing IONM for two hospitals, one of which is the largest medical center between Denver, Colorado and Salt Lake City, Utah.
  • Both hospitals serve residents in Western Colorado and Eastern Utah.
  • The strong organic growth Assure generated in 2019 is continuing in 2020, said John A. Farlinger, Assures executive chairman and CEO.